Brainomix, a pioneer in artificial intelligence (AI) imaging solutions, has entered into a partnership with Boehringer Ingelheim for a collaborative program of activity to improve the care of patients with fibrosing lung disease in the US. This project will focus on the opportunity for AI imaging analysis using Brainomix 360 e-Lung on routine CT scans to accelerate the diagnosis and improve access to treatment for people living with fibrosing lung disease. Pulmonary fibrosis is a chronic...